Centre d'Investigation Clinique - UF 1042 - CHRU Strasbourg - Nouvel Hôpital Civil

At the Centre d'Investigation Clinique - UF 1042 - CHRU Strasbourg - Nouvel Hôpital Civil, clinical research in female urogenital diseases and pregnancy complications focuses on women with recurrent implantation failure. The studies are designed to assess whether a new treatment approach can improve the chances of achieving a clinical pregnancy.

• Women with unexplained recurrent implantation failure
• Female urogenital and pregnancy-related conditions
• Testing treatment effectiveness for improving pregnancy outcomes

This work reflects a strong interest in reproductive health and in finding better options for patients facing repeated implantation difficulties.

Research at this CHRU Strasbourg site also covers immune system diseases and respiratory tract diseases, with a focus on severe asthma. The trial activity is aimed at understanding whether continuing or stopping an established treatment strategy offers the best long-term control for patients.

• Severe asthma
• Immune system and respiratory disease research
• Evaluating treatment durability and disease control

The studies are intended to support better management choices for people living with persistent asthma that remains under control with ongoing therapy.